Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Alvotech ( (ALVO) ) has provided an update.
On February 27, 2026, Alvotech reported that a major shareholder group restructured its internal holdings in the company. According to disclosures filed with Luxembourg’s financial regulator, ATP Holdings ehf., a party closely associated with CEO and chairman Róbert Wessman, sold 2,701,617 Alvotech shares on January 30, 2026, at USD 4.74 per share.
The same number of shares was acquired that day by Aztiq Pharma Partners S.à r.l., which belongs to the same Aztiq group as ATP Holdings, making the move an intra-group transfer rather than an external divestment. The transaction suggests no change in overall control by the Aztiq group but clarifies managerial and insider ownership structures for investors and regulators through formal market transparency filings.
The most recent analyst rating on (ALVO) stock is a Hold with a $5.00 price target. To see the full list of analyst forecasts on Alvotech stock, see the ALVO Stock Forecast page.
Spark’s Take on ALVO Stock
According to Spark, TipRanks’ AI Analyst, ALVO is a Neutral.
Alvotech’s overall stock score is driven by financial instability, bearish technical indicators, and regulatory challenges impacting short-term outlook. While strategic investments and historical growth are positives, significant risks remain.
To see Spark’s full report on ALVO stock, click here.
More about Alvotech
Alvotech is a Luxembourg-based biopharmaceutical company focused on developing and manufacturing biosimilar medicines. The company targets global markets with cost-effective alternatives to branded biologic therapies, positioning itself within the highly regulated European and U.S. healthcare and capital markets as a foreign private issuer.
Average Trading Volume: 511,352
Technical Sentiment Signal: Sell
Current Market Cap: $1.23B
For detailed information about ALVO stock, go to TipRanks’ Stock Analysis page.